Company ProfilePremium

SciDev Ltd

Company Profile Analysis

Ticker: SDV.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
SciDev Ltd - Company showcase

Year Founded & Workforce

1973

SciDev Ltd logo

SciDev Ltd Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

SciDev Ltd Overview

SciDev is an Australian micro-cap water-treatment technology and specialty-chemistry company. It combines three things: proprietary chemistry (MaxiFlox®, CatChek®, xSlik®), engineered treatment plants (including FluoroFIX®/RegenIX® PFAS systems and Build-Own-Operate fleets), and data/optimisation tools (Hydra-IQ™, OptiFlox®). It serves mining, infrastructure/tunnelling, US onshore oil and gas, and, newly, hyperscale data centres.

The company grew revenue from A$42.5m in FY21 to a record A$109.2m in FY24. It then contracted to A$85.5m in FY26 after losing a high-margin US friction-reducer contract and exiting loss-making US/UK water operations.

A June 2026 strategic review, led by new CEO Todd Scott, reset the business around an "integrated water solutions platform" focused on Mining, Data Centres and Energy. The stated priorities are recurring revenue (38% of FY26 revenue), capital discipline and cross-selling into a tier-one installed base.

SciDev now trades at roughly 0.65× book value with net cash. It is a turnaround story whose credibility depends on FY27 delivery.


Company's own description

In its FY26 results (27 August 2026), SciDev describes itself as a leading water-treatment technology company serving the mining, data centre and energy industries.

The FY26 Appendix 4E defines its two operating segments as follows:

Water Solutions: Specialised water treatment and remediation technologies, plus process chemistries for mining and construction. These remove contaminants from groundwater, surface water and industrial liquid waste so the water can be recycled or safely discharged.

Energy Services: Develops, manufactures and supplies specialty oilfield and production chemistries that improve efficiency, reduce waste and cut water consumption in the energy industry.

Earlier descriptions (FY24 Annual Report) framed SciDev as an "environmental solutions" company for water-intensive industries.

Business model and revenue model

SciDev earns revenue through five channels:

  1. Product sales (point-in-time).

    • Specialty chemistry sold to oilfield service companies and E&P operators in the US: CatChek® clay control, xSlik® premium friction reducer, and commodity-grade friction reducers.

    • Flocculants/coagulants sold to Australian mining and tunnelling clients: MaxiFlox®, MaxiDry™.

    • Goods transferred at a point in time were A$63.5m in FY26 (74% of customer revenue), down from A$85.6m in FY25 (83%) (FY26 Appendix 4E, Note 3).

  2. Design & Construct (D&C) contracts (over time). Water treatment plants built for construction contractors and mine-rehabilitation projects. The largest is the A$19.5m Rum Jungle groundwater treatment plant for McMahon Services in the Northern Territory.

  3. Build-Own-Operate (BOO) and Operations & Maintenance (O&M) services (over time). Redeployable PFAS and other treatment plants run under service contracts. For example, a ~A$2m Ventia BOO PFAS plant in Victoria and a multi-year PFAS treatment contract with a blue-chip mining client.

  4. Technical services and dose-control/monitoring hardware.

    • OptiFlox® dosing control (bundled with MaxiFlox® in the Newmont contract).

    • Hydra-IQ™ water-quality monitoring stations (e.g., 30 stations across Western Australian mines, FY24).

  5. Consulting/design. New in FY27: data-centre design, consulting and embedded engineering (~A$0.5m expected in 1H FY27).

Services transferred over time rose to A$21.9m in FY26 (26% of customer revenue) from A$17.7m in FY25. This reflects the shift toward project and O&M revenue.

There is no material subscription or licensing revenue. A small rental income line exists (A$0.15m FY26).

Recurring revenue. SciDev reported recurring revenue of 38% of FY26 revenue, up from 30% in FY25. Including CatChek® sales (short-term but repeat contracts), the figure would be 59%.

Definitional discrepancy: The 1H FY26 release reported recurring revenue of 54% using the broader definition that includes CatChek®. The full-year headline uses the narrower definition. Investors should compare like-for-like.

Value-chain position

SciDev sits mid-stream:

Upstream: It sources polymer feedstock and chemicals, partly through the Nuoer Group. A 50% joint venture, Nuoer SciDev JV Pte Ltd (Singapore), provides "secured feedstock" for MaxiFlox® (Investor Day, 17 June 2026). SciDev blends, formulates and applies chemistry rather than operating large-scale polymer production.

Downstream: It supplies field application, engineering design, plant construction, operations and data monitoring.

Differentiation: The company argues its edge lies in application know-how and proprietary formulations, not commodity volume.

Customer types and end-markets

End-marketCustomer typesFY26 share of revenue (company)
MiningGold/copper, mineral sands and legacy-mine remediation clients (Newmont Boddington, Iluka, a blue-chip WA miner, NT Government via McMahon Services)43%
Energy (US onshore oil & gas; Beetaloo Basin, Australia emerging)Oilfield service companies (including a tier-one provider under a new MSA) and E&P operators in the Permian, Eagle Ford, Haynesville and Utah basins43%
Infrastructure / constructionTier-1 tunnelling contractors (e.g., Acciona; contractors on Sydney Metro West and Western Harbour Tunnel), utilities/facility managers (Ventia), waste operators (Cleanaway New Chum landfill)14%
Data centres (new FY27)Two of Australia's largest hyperscale operators/developers~0% (first revenue in 1H FY27)

Source: FY26 results (Kalkine summary of FY26 announcement); company announcements.

By revenue mix (FY26): Water Solutions 56%, Energy Services 43%, exited international water 1%.

Customer concentration (FY24 Annual Report, Note 4):

  • One Chemical Services client contributed A$45.4m in FY24 (≈42% of group revenue), up from A$30.8m in FY23.

  • One Water Technologies client contributed A$6.5m in FY24.

The large Energy Services client concentration was the transmission mechanism for the FY26 xSlik® contract loss.

Independent characterisation

SciDev is best understood as two businesses under one listed roof:

  1. A cyclical, concentrated US oilfield-chemicals distributor-formulator (Energy Services, acquired via Highland Fluid Technology in 2020). It has one genuinely differentiated product (CatChek®) and exposure to frac-spread cycles and customer purchasing decisions.

  2. An Australian water-solutions contractor and chemistry supplier (Water Solutions). It is building recurring revenue via multi-year mining chemistry contracts, O&M and monitoring, and is now growing with a regulatory tailwind (PFAS, mine rehabilitation) plus an optional new vertical (data centres).

The FY26 reset effectively admits that the earlier global PFAS expansion was premature. The strategic review found that strong Energy Services earnings had masked a rising cost base and sub-scale entry into too many markets.

Strategy

Stated strategy (Investor Day, 17 June 2026; FY26 results, 27 August 2026)

Core theme. SciDev is resetting around an integrated water solutions platform that spans engineering, chemistry and data. It will target markets where it believes it has a genuine right to win: Mining, Data Centres and Energy (with Utilities & Infrastructure also cited as a core market). CEO Todd Scott acknowledged that the past year had cost the company shareholder trust.

Strategic review diagnosis. The review found that past cyclical strength in Energy Services had masked a rising cost base and poor capital allocation, including sub-scale entry into too many markets.

Corrective disciplines adopted:

  1. Business cases, hurdle rates and stage-gating for all capital decisions.

  2. Risk-weighted forecasting aligned to outlook visibility.

  3. Priority protection of key accounts, with added resourcing for new business development.

  4. Focus on core markets where SciDev can build scale.

Platform architecture (four layers):

  1. Engineering

  2. High-value chemistry

  3. Data monitoring (Hydra-IQ™, OptiFlox®)

  4. AI-driven optimisation (on the roadmap)

The first three layers are in market today.

Market sizing (company estimates):

  • ~A$4bn of addressable value across target industries in home markets.

  • A$30–45bn globally.

  • Water Solutions markets alone: ~A$2.2bn today, forecast to exceed A$6bn by 2040.

FY27 priorities (FY26 results):

  1. Expand engineering, chemistry and data services across the established mining client base.

  2. Establish a meaningful water-solutions position in data centres.

  3. Rebuild Energy Services growth through tier-one service-provider partnerships and expansion in the highest-demand CatChek® basins.

Initiatives announced in the last 24 months

InitiativeDateDetailTargets / status
International expansion (Europe, US PFAS)FY24–FY25Pilot plants, VP North America, Sweden/UK contractsReversed in 2H FY26
Channel-partner model for international waterAnnounced 25 Feb 2026; completed 2H FY26Exit of US/UK direct operations~A$3m in annualised costs removed from FY27
Corporate cost reduction1H–2H FY26Headcount and administration cutsCorporate costs −19% YoY in 1H FY26 (maintained); full-year corporate EBITDA loss −33%; group cost base ~A$4m lower vs FY25
Capex and working-capital disciplineFY26Lower capex (A$0.6m vs A$2.1m)Capital discipline framework presented at Investor Day
Energy Services diversificationFY26MSA and first revenue with a tier-one oilfield service provider; Permian expansion; Beetaloo Basin (Australia) discussionsCustomer concentration reduction (in progress)
New product development, EnergyFY26EnFlow (EOR), CatChek® variants, high-suspension slurriesPre-commercial
Data-centre entryInvestor Day 2026; first contracts 5 Aug 2026HydraCool reuse platform; team with 40+ European data-centre water projects and 10 years' experienceDesign consulting revenue in FY27 (~A$0.5m in 1H FY27); potential construction contracts in FY28
Data & optimisation commercialisationFY27Commercialise Hydra-IQ™ and OptiFlox®; aggregate datasetsFY27 objective
Cross-selling to mining installed baseFY27Sales function build-outNewmont Boddington win; several contracts in late trial/negotiation, including via the Nuoer JV
Recurring-revenue growthOngoingMulti-year process chemistry, O&M, CatChek®30% (FY25) → 38% (FY26) narrow definition; no numeric target set

Sustainability / ESG commitments

The company has developed an ESG framework, a refreshed purpose statement and values (FY23). No quantified emissions or ESG targets were found in the sources reviewed.

Management guidance and targets

No formal FY27 guidance: Management said it would replace forecasts with delivery.

Disclosed forward indicators (17 June 2026): - Firm FY27 order book of ~A$39m in revenue.

  • Submitted open tender pipeline of ~A$115m.

Medium-term financial targets: None publicly quantified.

Products & Services

Pricing is not publicly disclosed for any product. All products are sold on project, contract or per-volume terms.

Water Solutions — Process Chemistry

Product / offeringDescription & capabilitiesTarget customerLaunch / latestFlagship evidence
MaxiFlox®Proprietary flocculant chemistry for solids-liquid separation (tailings, thickening, dewatering). Supported by feedstock secured through the Nuoer JV.Gold/copper and mineral-sands miners; resellers in Turkey and MexicoLong-standing; current-generation date not disclosedNewmont Boddington (~A$6.0m over 3 years from 1H FY27); Iluka; Thunderbird mineral sands (~A$7.0m over 2 years)
MaxiDry™Chemistry and services for tunnelling spoil and slurry management (dewatering, spoil conditioning).Tier-1 tunnelling contractors—NSW tunnelling contract awarded Q2 FY24; "large-scale tunnelling infrastructure projects" drove record FY26 Process Chemistry revenue
OptiFlox®Automated dose-control and optimisation technology paired with flocculant supply. Part of the "data & optimisation" layer.Mining processing plantsCommercialisation priority for FY27Bundled in the Newmont Boddington contract
Technical servicesOn-site application engineering and process optimisation.Mining and construction—Embedded in multi-year mining contract renewals

Water Solutions — Water Technologies (APAC)

Product / offeringDescription & capabilitiesTarget customerLaunch / latestFlagship evidence
FluoroFIX® / FluorofIX™Proprietary PFAS treatment technology (adsorbent/media-based process) used in BOO and D&C plants. Pilot plants built in Europe and North America (FY24).Defence, mining, landfill, utilities, constructionPilot plants FY24; commercial use since at least FY21>1bn litres of PFAS-contaminated water treated for a blue-chip miner (A$4.7m two-year extension, FY24); Ventia BOO (~A$2m)
RegenIX™ / RegenIX®Regenerable ion-exchange PFAS concentration/destruction-support process; submitted to the US DoD ESTCP programme (FY24).Defence, utilities, industrial—Independent validation of FluorofIX and RegenIX cited (Simply Wall St narrative, Dec 2025)
Build-Own-Operate (BOO) treatment fleetRedeployable treatment plants for short-duration contaminated water work; O&M contracts.Utilities, infrastructure, mine sitesOngoing7–9 concurrent PFAS projects in FY24 quarters (e.g., Q4 FY24: 7 projects, A$3.8m revenue)
Design & Construct (D&C) water treatment plantsPermanent multi-stage treatment plants (AMD, radiological, metals).Mine-rehabilitation owners, tunnelling contractorsOngoingRum Jungle 30 L/s plant (A$19.5m; operational target 4 Sep 2026; option for 2-year O&M; potential 15-year O&M); Western Harbour Tunnel WTP (A$4.75m); Acciona D&C (A$4.6m); New Chum landfill (Cleanaway)
Hydra-IQ™Water-quality monitoring stations and data platform; sales grew in FY26.Mine operatorsFY24 deployments; commercialisation priority FY2730 monitoring stations for a blue-chip WA miner (FY24)
HydraCoolPurpose-built water reuse platform for data-centre cooling water.Hyperscale data-centre operatorsIntroduced at Investor Day, June 2026First design/consulting contracts with two hyperscalers (Aug 2026)

Energy Services (US-based; Beetaloo Basin, Australia, emerging)

Product / offeringDescription & capabilitiesTarget customerLaunch / latestFlagship evidence
CatChek® (incl. CatChek™ 12S and new variants)Clay control/stabilisation chemistry for hydraulic fracturing. Company states it is independently verified across 3,000+ wells to deliver higher BOE uplift and less wastewater; ~2% market share.E&P operators and oilfield service companiesOngoing; new variants in development (FY26)Sales +51.5% in FY24 and +46% in FY25; 51% of Energy Services revenue in FY26 (up from 41%); clients buying CatChek® +75% YoY in 1H FY26
xSlik®Premium friction-reducer chemistry for slickwater fracs using recycled water. Was among Energy Services' highest-margin products.Oilfield service companies—Key contract lost in FY26: ~A$8.6m lower EBITDA vs FY25 at group level; ~A$5m of the segment decline
Commodity friction reducersStandard-grade friction reducers.Oilfield service companies—Faced intensified price competition in FY26
EnFlow (in development)Enhanced Oil Recovery chemistry.E&P operatorsUnder development (FY26)Not yet commercial
High-suspension slurries (advanced delivery systems)Concentrated delivery formats for chemistry.Service companiesUnder development (FY26)Not yet commercial
TrueMud™ / fluid technology services (HFT legacy)Patent-pending lightweight drilling-fluid mixer and formulation services.Majors / large operators2020–21ExxonMobil purchase orders (2020; extension Feb 2021). Current activity not disclosed.
R&D contract servicesFormulation R&D.Qatar Shell GTL LtdRenewed FY24Contract renewal disclosed in FY24 Annual Report

Exited / restructured offerings

International Water Technologies (US, UK, Europe)

  • Direct PFAS and industrial-water operations were closed in 2H FY26. The business moved to a channel-partner sales model.

  • FY26: revenue A$0.5m, underlying EBITDA loss A$2.1m.

  • 1H FY26 loss alone was A$1.5m.

  • First Swedish and UK contracts had been secured in 1H FY25.

Financial Narrative

Sources by year:

  • FY2022: FY24 Annual Report remuneration KPM table; FY22 opening balances in the FY24 statement of changes in equity

  • FY2023–FY2024: FY24 Annual Financial Report

  • FY2025–FY2026: FY26 Appendix 4E (FY25 comparatives as restated)

  • FY2026 figures are unaudited as at 27 August 2026.

FY2021 reference points (FY24 Annual Report KPM table): revenue A$42.5m; NPAT A$3.45m; EPS 2.26c.

Income statement

Notes on the income statement:

FY24 revenue: The CEO's quote and the Q4 update cite A$109.3m; the statutory figure is A$109.236m.

FY22 EBITDA: Full-year FY22 EBITDA was not available in the sources reviewed. 1H FY22 EBITDA was −A$0.4m.

Revenue CAGR (analyst calculation):

  • FY22–FY26 (4 years): 11.4%

  • FY21–FY26 (5 years): 15.0%

  • FY21–FY24 peak (3 years): 37.0%

FY26 significant items (FY26 Appendix 4E) — these bridge underlying EBITDA (A$3.60m) to reported EBITDA (−A$1.10m) for EBITDA-level items:

Effective tax anomaly in FY25. FY25 tax expense was A$2.33m on a pre-tax profit of A$1.46m, turning a pre-tax profit into a net loss. The structural cause is that overseas (US) profits are taxed while Australian losses are not recognised. FY24 disclosed A$55.2m of unused tax losses without a recognised deferred tax asset (potential benefit A$16.4m). This is a latent value item if Australian profitability is sustained.

Balance sheet

Notes on the balance sheet:

  • The FY24 interest-bearing liability of A$2.32m was the deferred Haldon vendor payable (12% interest, related party). FY25–FY26 debt is Westpac bank debt.

  • Goodwill at 30 June 2026 is allocated across three cash-generating units: Energy Services A$7.5m, Process Chemistry A$3.0m, Water Technologies A$10.1m.

Cash flow

Notes on cash flow:

  • SciDev reports "underlying operating cash flow" of A$6.0m for FY26. Statutory operating cash flow was A$3.6m. The difference reflects company adjustments (e.g., restructuring cash and tax refunds).

Half-year pattern conflict: The FY26 announcement table shows underlying OCF of A$2.9m (1H) and A$6.0m (2H). The text describes A$6.0m as the full-year total. This is internally inconsistent in the released document and should be confirmed against the audited Annual Report.

Ratios (analyst calculations, year-end balances)

Note: The FY24 cash conversion cycle excludes A$4.9m of contract assets. Including them, FY24 DSO is about 41 days and the CCC about 5 days.

Commentary on trends, inflections and drivers

Growth phase (FY21–FY24). Revenue rose from A$42.5m to A$109.2m. Three acquisitions drove this:

  • HFT (2020) took the US oilfield business from zero to a majority of revenue: US revenue was A$61.2m in FY24.

  • Haldon (2021) built the Water Technologies/PFAS platform.

  • Organic growth came from MaxiFlox® mining contracts and tunnelling projects.

FY24 was the profitability peak: underlying EBITDA A$8.8m (8.1% margin), NPAT A$2.2m, operating cash flow A$6.5m. Management attributed the margin gain to moving US customers from commodity to proprietary products (CatChek®, xSlik®).

Stall (FY25). Revenue fell 5% to A$103.4m:

  • Water Technologies dropped 26% because domestic contracts were delayed.

  • Management deliberately de-emphasised commodity chemistry.

  • Underlying EBITDA fell to A$7.1m as SciDev invested in international sales, engineering and project governance.

  • Water Technologies also had projects needing costly rework (later reflected in the FY26 "ISO asset rectification" item).

  • Tax leakage produced a net loss despite a pre-tax profit.

Break (FY26). Revenue fell 17% to A$85.5m. Underlying EBITDA halved to A$3.6m. Two causes explain the entire EBITDA variance:

  1. The xSlik® contract loss (−A$8.6m EBITDA), on top of weak US frac activity.

  2. International water losses (−A$2.1m).

Offsets were record Water Solutions EBITDA (A$4.2m, +A$3.6m) and a 33% cut in corporate costs (+A$1.6m). Statutory NPAT was −A$5.8m, including the A$2.85m write-off of Haldon customer contracts and IP.

Second-half inflection. 2H FY26 underlying EBITDA was A$2.5m on revenue of A$37.6m (6.7% margin), versus A$1.1m on A$47.9m in 1H (2.3%). This suggests the cost-out is real. The 2H margin is also flattered by Rum Jungle construction revenue, which is non-recurring at that scale.

Balance sheet. The balance sheet is conservative: net cash in every year, A$13.8m total liquidity at 30 June 2026, and debt-to-equity below 0.15×. The company has never paid a dividend and does not buy back shares. Working capital swings are large relative to EBITDA. Net cash fell to A$1.4m at 31 May 2026 because of Rum Jungle working capital, then recovered to A$6.8m by 30 June 2026.

Guidance credibility. This is the central financial issue. FY26 revenue guidance went from A$120–140m (August 2025) to A$100–110m (February 2026) to A$82–87m (April 2026). Actual revenue of A$85.5m landed in the final range. Management has since said it will stop giving formal forecasts. No FY27 guidance was issued.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Income Statement and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Revenue (AUD Mn)

55.689.8109.2103.485.5

Revenue growth YoY (%)

30.761.621.6-5.4-17.3

Company-reported gross margin (%)

———2826

Revenue less materials & consumables (AUD Mn), analyst calc.

—24.334.134.527.3

Materials margin (%), analyst calc.

—27.031.233.432.0

Employee benefits expense (AUD Mn)

—12.616.118.016.9

Reported EBITDA (AUD Mn)

—3.928.846.19-1.10

Underlying / adjusted EBITDA (AUD Mn)

—4.088.847.133.60

Depreciation & amortisation (AUD Mn)

—3.514.094.174.21

EBIT (AUD Mn), PBT plus finance costs

—0.414.752.02-5.31

Finance costs (AUD Mn)

—0.630.650.570.51

Profit before tax (AUD Mn)

—-0.224.101.46-5.82

Income tax expense (AUD Mn), benefit negative

—0.121.932.33-0.05

Net profit after tax (AUD Mn)

-0.62-0.342.18-0.88-5.77

Basic EPS (A$ cents)

-0.35-0.181.15-0.5-3.0

Diluted EPS (A$ cents)

—-0.181.13-0.5-3.0

Dividends per share (A$ cents)

00000

Underlying EBITDA margin (%)

—4.58.16.94.2

EBIT margin (%)

—0.54.42.0-6.2

Net margin (%)

-1.1-0.42.0-0.8-6.7

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Financials

Item (AUD Mn)FY2025FY2026

Impairment of intangible assets, Haldon (AUD Mn)

02.845

Restructuring incl. redundancies (AUD Mn)

01.030

ISO asset rectification (AUD Mn)

00.637

UK subsidiary wind-down costs (AUD Mn)

00.190

Transaction costs incl. due diligence (AUD Mn)

0.9380

Balance Sheet and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (AUD Mn)

—67.472.075.261.8

Cash & equivalents (AUD Mn)

14.17.79.49.78.6

Trade & other receivables, current (AUD Mn)

—7.57.415.012.0

Contract assets, current (AUD Mn)

—0.64.90.60.3

Inventories (AUD Mn)

—6.97.57.45.9

Goodwill (AUD Mn)

20.620.920.821.020.6

Goodwill & intangibles total (AUD Mn)

25.925.625.024.721.0

Bank / interest-bearing debt, current (AUD Mn)

—02.321.530.53

Bank / interest-bearing debt, non-current (AUD Mn)

—001.811.29

Lease liabilities, total (AUD Mn)

—3.482.812.921.74

Total debt incl. leases (AUD Mn)

—3.485.136.263.55

Net cash, company definition (AUD Mn), cash less bank loans

—7.737.116.346.75

Net cash incl. leases (AUD Mn), analyst calc.

—4.254.303.425.01

Total equity (AUD Mn)

48.848.050.250.143.0

Net working capital (AUD Mn)

—6.69.912.111.6

NTA per share (A$ cents)

—11.8013.2713.3111.56

Cash Flow

MetricFY2023FY2024FY2025FY2026

Operating cash flow, statutory (AUD Mn)

4.816.482.873.61

Capex, PP&E plus intangibles (AUD Mn)

4.292.072.120.59

Free cash flow, OCF less capex (AUD Mn)

0.524.420.753.02

Lease principal payments (AUD Mn)

3.011.071.291.35

FCF after leases (AUD Mn)

-2.493.35-0.551.66

Business acquisition payments (AUD Mn)

3.621.5900

Related-party loan repayment, Haldon (AUD Mn)

002.380

Dividends paid (AUD Mn)

0000

Share buybacks (AUD Mn)

0000

Net bank borrowing / (repayment) (AUD Mn)

003.50-1.60

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2023FY2024FY2025FY2026

ROE (%)

-0.74.3-1.8-13.4

ROA (%)

-0.53.0-1.2-9.3

ROIC (%), NOPAT at 30% tax / (equity + debt incl. leases − cash)

0.77.23.0-9.8

Current ratio (x)

1.391.491.561.70

Debt-to-equity incl. leases (x)

0.070.100.130.08

Net debt / underlying EBITDA (x), negative = net cash

-1.04-0.49-0.48-1.39

Interest coverage, underlying EBITDA / finance costs (x)

6.513.612.67.1

Asset turnover (x)

1.331.521.371.38

DSO, trade receivables (days)

30255351

DIO, inventory / materials cost (days)

39373937

DPO, trade payables / materials cost (days)

62736958

Cash conversion cycle (days)

7-112330

Revenue by Region

RegionFY2023FY2024FY2025FY2026

Australia revenue (AUD Mn)

31.945.341.746.0

United States revenue (AUD Mn)

55.861.260.737.1

Asia revenue (AUD Mn)

1.040.570.390.83

Other revenue (AUD Mn), incl. Europe/UK and resellers

1.011.960.491.41

Total customer revenue (AUD Mn)

89.7109.1103.285.4

Region Margins & Growth (%) and Revenue by Region (%)

RegionFY2024FY2025FY2026

Australia YoY growth (%)

42.0-8.110.5

United States YoY growth (%)

9.8-0.9-38.8

Australia share of revenue (%)

41.640.453.9

United States share of revenue (%)

56.158.843.5

Share Price

MetricFY2020FY2021FY2022FY2023FY2024

Share price at 30 June (AUD)

0.580.850.180.330.37

Share Price & Returns

PeriodApproximate returnBasis

1-year

−55%

~A$0.33 (Oct/Nov 2025) to A$0.148

3-year

−50% to −55%

Roughly A$0.30–0.33 (Oct 2023) to A$0.148; Oct 2023 price not precisely verified

5-year

about −80%

—

Valuation Snapshot

MetricValue

Market capitalisation

A$28.1m

Enterprise value (market cap + bank debt A$1.81m + leases A$1.74m − cash A$8.57m)

A$23.1m

P/E (FY26)

Not meaningful (loss)

EV / underlying EBITDA (FY26)

6.4×

EV / 2H FY26 annualised underlying EBITDA (A$5.0m)

4.6×

EV / Sales (FY26)

0.27×

P/B (equity A$42.95m)

0.65×

P/NTA (11.56c)

1.28×

Capital Markets

ItemDetail

Dividend history

No dividends paid, recommended or declared in FY22–FY26 (FY24 Annual Report; FY26 Appendix 4E)

Dividend policy

None stated; capital directed to organic growth

Buybacks

None authorised or executed

Credit ratings

No Moody's / S&P / Fitch ratings (unrated)

Debt facilities

Westpac A$10m package (Aug 2024): A$5m revolver, A$2m equipment finance, up to A$3m amortising. A$7.0m unutilised at 30 Jun 2026.

Debt maturity profile (30 Jun 2026)

Current interest-bearing A$0.53m; non-current A$1.29m; leases A$0.74m current and A$1.00m non-current. Detailed maturity ladder not disclosed in the Appendix 4E.

Analyst Conclusions

Management guidance and forward indicators

No FY27 revenue or EBITDA guidance: Management has explicitly moved from forecasts to delivery-based communication.

Disclosed forward indicators: - FY27 firm order book ~A$39m (as at June 2026).

  • Submitted tender pipeline ~A$115m.

  • Newmont Boddington ~A$2m a year from 1H FY27.

  • Data-centre consulting ~A$0.5m in 1H FY27.

  • Remaining ~50% of Rum Jungle revenue (~A$9–10m) recognised in FY27.

  • ~A$3m of annualised international costs removed from FY27.

Consensus: Not available.

Analyst illustration (not a forecast). If Energy Services stabilises at the FY26 run-rate, Water Solutions sustains its 2H FY26 margin, and corporate costs hold at the FY26 exit level, FY27 underlying EBITDA could plausibly exceed FY26's A$3.6m. This depends on replacing Rum Jungle construction revenue in FY28. This is an analytical scenario, not company guidance.

Bull case

  1. Leaner cost base with operating leverage. About A$4m of costs removed, and a 6.7% underlying EBITDA margin in 2H FY26 despite lower revenue. Any Energy Services recovery or Water Solutions growth flows through at high incremental margin.

  2. Recurring-revenue quality improving. Recurring revenue rose from 30% to 38%. Multi-year contracts (Newmont; potential Rum Jungle 15-year O&M) support a re-rating toward water-infrastructure multiples.

  3. Asymmetric valuation. EV of ~A$23m against A$85.5m revenue (0.27×) and 0.65× book. Net cash, about A$16m of potential tax benefit from unrecognised losses, and new optionality (data centres, CatChek® via a tier-one oilfield service channel, Beetaloo Basin).

Bear case

  1. Credibility and forecasting. FY26 guidance was cut by about 35% from midpoint to actual. The CEO and CFO changed, and the auditor changed. The market may refuse to pay for pipeline until several clean halves are delivered.

  2. Energy Services remains concentrated and cyclical. Commodity friction-reducer competition persists. CatChek® is ~51% of a shrinking segment. Another customer loss would be material against a A$3.6m EBITDA base.

  3. Lumpy Water Solutions earnings. The FY26 Water Technologies APAC profit was largely Rum Jungle construction. Without a comparable D&C win, FY28 faces a revenue hole. Data centres are unproven and are unlikely to deliver construction revenue before FY28.

Key catalysts and monitorables (next 12 months)

  1. 2026 AGM (late 2026): board composition, CFO appointment status, remuneration votes.

  2. Rum Jungle commissioning and handover (target September 2026), and award of the O&M extension.

  3. Appointment of a permanent CFO.

  4. 1H FY27 results (expected around February 2027): first test of the reset, including 1H underlying EBITDA versus A$1.1m in 1H FY26.

  5. Conversion of the ~A$115m tender pipeline; additional mining chemistry contracts (including through the Nuoer JV).

  6. Data-centre progression from consulting to construction-phase awards.

  7. US frac spread counts; CatChek® volumes through the tier-one oilfield service MSA; Beetaloo Basin supply decision.

  8. Working-capital behaviour (net cash trajectory) and any capital-raising signals.

  9. Substantial-holder movements (Mercer 8.82%) and director trading.

Analyst verdict

SciDev enters FY27 as a smaller but cleaner business than the one that reported record results two years ago. The FY26 numbers are poor in absolute terms: revenue down 17%, underlying EBITDA halved, a statutory loss of A$5.8m. Underneath them, however, are two encouraging facts.

First, the Australian Water Solutions franchise had its best year: A$4.2m of underlying EBITDA on 13% revenue growth, supported by tier-one mining, tunnelling and remediation clients.

Second, management acted decisively on what failed. It exited sub-scale international water operations, cut corporate costs by a third, reduced capex sharply and rebuilt net cash to A$6.8m. The second-half margin recovery to 6.7% suggests these actions are real.

The investment debate now turns less on strategy, which is coherent, than on execution and visibility. The integrated engineering-chemistry-data platform makes sense for a company whose clients already buy two of the three layers. The danger is that SciDev's earnings remain hostage to two volatile pillars: one US oilfield business still exposed to customer concentration and frac cycles, and a project-heavy water business that must replace Rum Jungle's construction revenue.

Management's refusal to guide is defensible after two downgrades. It also means investors must underwrite the turnaround from the order book (~A$39m) and pipeline (~A$115m) alone.

At about 0.27× EV/Sales, 0.65× book, with net cash and a potentially valuable unrecognised tax shield, the market is pricing SciDev close to a no-growth, ongoing-disappointment scenario. That creates asymmetric upside if 1H FY27 confirms the 2H FY26 run-rate, Rum Jungle transitions into long-term O&M, and either data centres or CatChek® channel partnerships produce visible revenue.

Verdict: a speculative, execution-dependent turnaround. The 1H FY27 result is the critical proof point. Until then, conviction should stay modest despite the apparent valuation support.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenurePrior roles / education

Todd Scott

Chief Executive Officer

CEO since 26 May 2026; CFO from 27 Oct 2025

Group VP Investor Relations, Sims Ltd; equity research analyst at ABN AMRO Equities (Australia) and RBS Equities (Australia)

John Gardiner

Interim Chief Financial Officer

Since 26 May 2026

—

Heath L. Roberts

Company Secretary & General Counsel

Engaged since 1 Mar 2017

Commercial solicitor; 21+ years of listed-company experience; Dip Law (SAB), Grad Dip Legal Practice (UTS)

“—” = not publicly disclosed.

Board of Directors

NameRoleAppointedBackgroundIndependence

Michael (Mike) Utsler

Non-executive Chair

NED 1 Mar 2024; Chair 1 Apr 2025

40+ years in energy (Amoco, BP incl. President of the Gulf Coast Restoration Organisation, SVP BP Alaska Exploration; Woodside; New Fortress Energy); ex-CEO/Exec Chair Otto Energy; NED Santos Ltd (from May 2022); ex-director Oil Search. BSc (Petroleum Eng), GAICD. Age 69 (MarketScreener).

Independent

Dan O'Toole

Non-executive Director

3 Feb 2021

36+ years in engineering consulting; ex-CEO Pitt & Sherry; executive at Coffey International; co-founder of Viotel. BEng (Hons), FIEAust.

Independent

Johannes Risseeuw

Non-executive Director

1 Apr 2025

Experienced director in corporate strategy, governance, commercial matters and M&A.

Independent (presumed)

Jon Gourlay

Non-executive Director (status unclear)

28 May 2019

Chartered accountant; ex-Newcrest, Glencore Zinc; Principal Advisor to the Treasurer of Tasmania. BCom, CA, GAICD.

Independent

Board of Directors by Name / Role

Name / role (FY24)Salary & fees (AUD)Bonus (AUD)Superannuation (AUD)Share-based (AUD)Total (AUD)

Seán Halpin, CEO

360,50093,34827,39958,333539,580

Anna Hooper, CFO

336,22555,87027,39941,666461,160

Heath Roberts, CoSec & GC

205,000000205,000

Vaughan Busby, Chair

95,000010,4500105,450

Simone Watt, NED

60,00006,600066,600

Jon Gourlay, NED

60,00006,600066,600

Dan O'Toole, NED

60,00006,600066,600

Michael Utsler, NED (from 1 Mar 2024)

20,00002,200022,200

Major Shareholders

HolderShares% of issued capitalDate / source

Mercer Investments (Australia) Ltd (WSSP Australian Equities Trust; Mercer Australian Small Companies Fund)

16,773,2678.82

Form 604, 29 Jun 2026 (up from 7.01%)

Unnamed institutional holder (custodian JPMorgan Nominees Australia)

Sold below 5%

ceased

Form 605; ceased 28 Apr 2026 after selling ~3.6m shares on 21–28 Apr 2026

Haldon Industries Pty Ltd (Halpin-associated)

5,100,0002.7

FY24 Annual Report (escrow to 15 Sep 2024); current holding not disclosed

Seán Halpin (direct/other)

1,000,0000.5

FY24 Annual Report; current not disclosed

Simone Watt (former director)

5,313,2802.8

FY24 Annual Report; current not disclosed

Jon Gourlay

1,371,5510.7

Market Index, notice 29 Apr 2026

Mike Utsler

750,1840.4

Market Index, notice 14 May 2026

Dan O'Toole

328,111 shares (plus 624,525 in a second disclosure column, likely rights)

0.2

Market Index, notice 1 May 2026

Johannes Risseeuw

250,000 (column classification unclear)

0.1

Market Index, notice 29 Apr 2026

Competitive Landscape

Competitors by Segment

SegmentCompetitorTypeRelative positioning vs SciDev

Process Chemistry (flocculants, mining)

SNF Group (France)

Private global polyacrylamide leader

Massive scale and integrated polymer production; SciDev competes on application service and feedstock via Nuoer

Process Chemistry

Solenis (incl. ex-BASF flocculants business)

Private

Global mining reagents scale

Process Chemistry

Kemira Oyj (Finland)

Listed

Water/process chemicals scale; Australian presence

Process Chemistry / water treatment

Ecolab (Nalco Water)

Listed (US)

Dominant integrated water-treatment services

Water Technologies (PFAS, D&C, BOO)

Veolia Water Technologies

Listed (France)

Global treatment engineering; large-project balance sheet

Water Technologies (PFAS, Australia)

Specialist PFAS contractors (e.g., foam-fractionation and remediation firms)

Mostly private

Fragmented niche; SciDev claims a 40+ project track record

Energy Services (friction reducers, clay control)

SLB (incl. ChampionX production chemicals)

Listed

Scale chemical provider

Energy Services

Halliburton (Multi-Chem)

Listed

Integrated service company; potential customer and competitor

Energy Services

Innospec (Oilfield Services segment)

Listed (US)

Specialty oilfield chemistry

Energy Services

Flotek Industries

Listed (US)

Closest small-cap analogue in completion chemistry

Energy Services

SNF / Kemira (friction-reducer polymers)

—

Commodity friction-reducer supply; driver of FY26 price competition

Data-centre water

Veolia, Ecolab, engineering consultancies

—

SciDev's claim: early position with no established incumbent (company view)

Peer Comparison FY2026

MetricSciDev (FY26)Flotek (CY2024)Innospec (CY2024)Kemira (CY2024)

Revenue

A$85.5m

~US$187m

~US$1.85bn

~EUR 2.95bn

Revenue growth

−17%———

EBITDA margin

4.2% (underlying)

———

Company Snapshot

$55.2M

Revenue

1973

Founded

Sydney, Australia

Headquarters

SWOT Analysis

Strengths

  • Net cash balance sheet. Net cash A$6.75m and total liquidity A$13.8m (A$7.0m of undrawn facilities) at 30 June 2026. Debt-to-equity incl. leases 0.08× (FY26 Appendix 4E).
  • Water Solutions profit turnaround. Record underlying EBITDA of A$4.2m in FY26, up from A$0.6m in FY25, on revenue +13% to A$48.3m. APAC Water Technologies swung from −A$0.8m to +A$2.0m.
  • CatChek® resilience. Rose to 51% of Energy Services revenue in FY26 (from 41%) despite a 39% segment revenue decline. Customers buying CatChek® grew 75% YoY in 1H FY26.
  • Tier-one client validation. Newmont Boddington (~A$6.0m), Rum Jungle (A$19.5m), the A$4.7m PFAS extension with a blue-chip miner (>1bn litres treated), and Tier-1 tunnelling contracts worth A$9.35m.
  • Rising recurring revenue. 38% of FY26 revenue (30% FY25), or 59% including CatChek®.
  • Demonstrated cost-out. Corporate EBITDA loss cut 33% to A$3.2m; ~A$3m of annualised international costs removed. 2H FY26 underlying EBITDA margin of 6.7% vs 2.3% in 1H.

Weaknesses

  • Loss-making at the statutory level. FY26 NPAT −A$5.77m (EPS −3.0c). Three of the last five years were statutory losses (FY22, FY23, FY25 as well as FY26).
  • Customer concentration. One client was A$45.4m (≈42%) of FY24 revenue. Loss of the xSlik® contract cut A$8.6m from group EBITDA.
  • Forecasting failures. FY26 guidance fell from A$120–140m to A$82–87m within eight months.
  • Failed acquisition value. Haldon customer contracts and IP fully impaired (A$2.85m) in FY26.
  • Tax leakage. FY25 tax expense of A$2.33m on pre-tax profit of A$1.46m. A$55m of Australian losses unrecognised (FY24).
  • Uneven cash conversion. Statutory FCF after leases was negative in FY23 (−A$2.5m) and FY25 (−A$0.5m).

Opportunities

  • Rum Jungle O&M annuity. A 2-year option, and the company says it is well positioned for the full 15-year O&M programme after plant completion (Sept 2026 target).
  • Data centres. Initial hyperscale contracts (Aug 2026), with construction contracts possible in FY28. The team has delivered 40+ European data-centre water projects.
  • Mining cross-sell. Order book ~A$39m and tender pipeline ~A$115m (June 2026). Several mining chemistry contracts in late trial or negotiation, including through the Nuoer JV.
  • CatChek® runway. ~2% share. A tier-one oilfield service MSA provides a channel. Beetaloo Basin (Australia) supply discussions.
  • PFAS regulation. US EPA PFAS drinking water rules and tightening Australian standards. SciDev holds NSW EPA mobile PFAS processing licences 20878 and 21114.
  • Unrecognised tax losses. A potential benefit of A$16.4m (FY24 disclosure) if Australian profitability is sustained.

Threats

  • US frac cycle. Declining frac spread counts for most of FY26 and intensifying commodity friction-reducer competition.
  • Global incumbents. SNF, Solenis, Kemira, Ecolab/Nalco and Veolia have scale advantages in chemistry and large treatment projects.
  • Project execution risk. Rum Jungle delays (weather, shipping) and FY26 ISO asset rectification costs (A$0.64m).
  • Leadership and continuity risk. CEO change (May 2026), interim CFO, auditor change (Feb 2026), board turnover (2024–2025).
  • FX. The US business is reported in A$. The 1H FY26 guidance revision cited a A$3m FX impact.
  • Equity overhang and capital-raise risk. Market cap is ~A$28m. Any growth investment beyond the A$13.8m of liquidity could require dilutive equity at a depressed price.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
1 Apr 2025Board refresh: Utsler becomes Chair; Halpin becomes MD; Risseeuw appointed; Busby departs; Gourlay retirement flagged.Governance transition toward energy/industrial expertise
7 May 2025Q3 FY25 revenue of A$26.3m (+10% quarter-on-quarter); shares +5%.Last clean growth quarter before the downturn
Late FY25CatChek® trials and Permian traction; CatChek® sales +46% in FY25; xSlik® product trials completed late FY25.Energy product momentum (later reversed for xSlik®)
FY25A$5.6m water contract plus multiple Australian Water Technologies wins.Domestic water pipeline
27 Aug 2025FY25 results: revenue A$103.4m, underlying EBITDA A$7.1m, closing cash A$9.7m. FY26 revenue range of A$120–140m set.Guidance later proved materially overstated
20 Nov 20252025 AGM.Routine
26–27 Oct 2025Todd Scott appointed CFO, replacing Anna Hooper.Sets up later CEO succession
3 Nov 2025A$19.5m Rum Jungle groundwater treatment plant contract; shares jump ~38%.Largest single Water Technologies contract; potential 15-year O&M annuity
23 Dec 2025Mercer substantial holding notice (7.01%).Institutional support
4 Feb 2026BDO appointed auditor after EY resignation (ASIC consent; no disagreements stated).Governance/cost; watch item
25 Feb 20261H FY26: revenue A$47.9m (−4%), underlying EBITDA A$1.1m (vs A$3.4m), reported EBITDA A$0.4m, net loss ~A$2.1m. Frac schedule change at a key US customer removed most xSlik® volume (−A$3.6m EBITDA). FY26 guidance cut to A$100–110m.Share price fell from A$0.345 to about A$0.12 over following weeks
25 Feb 2026International Water Technologies moves to a channel-partner model (~A$3m annual savings). Process Chemistry posts record 1H revenue (A$14.5m, +16%). APAC Water Technologies returns to profit.Strategic pivot begins
26 Feb 20261H FY26 earnings call.Disclosure event
20 Apr 2026Trading update: FY26 revenue cut to A$82–87m; underlying EBITDA ~A$4m. Rum Jungle revenue partly deferred to FY27 (weather, shipping). Corporate costs −19%.Second downgrade in two months
21–28 Apr 2026Institutional holder (JPMorgan Nominees custody) sells ~3.6m shares and ceases to be a substantial holder.Institutional exit at the lows
29 Apr – 14 May 2026Director on-market purchases (Gourlay, Risseeuw, O'Toole, Utsler).Insider confidence signal
26 May 2026Halpin resigns as MD & CEO; Todd Scott becomes CEO; John Gardiner becomes Interim CFO.Leadership reset
9 Jun 2026Investor Day webinar details released (share price ~A$0.088, near the low).—
17 Jun 2026Strategic Review outcomes and Investor Day. FY26 guidance confirmed. Net cash A$1.4m at 31 May 2026 (Rum Jungle working capital). Order book ~A$39m; pipeline ~A$115m.Strategy reset; stock re-rated from the lows
23 Jun 2026~A$6.0m Newmont Boddington contract (3 years plus 1).Tier-one mining recurring revenue
29 Jun – 2 Jul 2026Mercer lifts its stake to 8.82% (bought 3.45m shares at A$0.105–0.115).Institutional accumulation
2H FY26Exit of US/UK direct water operations completed; UK subsidiary wound down.Cost base removed
FY26MSA and first revenue with a tier-one oilfield service provider; Beetaloo Basin opportunities.Energy diversification
5 Aug 2026First data-centre contracts with two Australian hyperscale operators (~A$0.5m in 1H FY27); shares +22% intraday.New vertical; optionality
6 Aug 2026Results date notice (27 Aug webcast with CEO Scott and Interim CFO Gardiner).—
27 Aug 2026FY26 results: revenue A$85.5m; underlying EBITDA A$3.6m; reported EBITDA −A$1.1m; NPAT −A$5.8m; net cash A$6.8m; recurring revenue 38%; Haldon intangible impairment A$2.85m. No FY27 guidance. Shares −2% to ~A$0.148.Within the twice-reduced guidance; 2H recovery
4 Sep 2026 (target)Rum Jungle plant contractual operational date.Completion status not publicly confirmed in sources reviewed
29 Sep 20262026 Annual Report and Corporate Governance Statement / Appendix 4G lodged.Audited FY26 accounts
1 Oct 20262026 AGM date and call for director nominations.AGM expected Nov 2026 (exact date not captured)
Sept 2026 (post-FY26 results)FY24 LTI tested on FY26 EPS (hurdle almost certainly not met).Remuneration outcome; not separately disclosed

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Income Statement: Revenue & Gross Profit: Revenue rose from AUD 55.6 Mn in FY2022 to AUD 85.5 Mn in FY2026.
SciDev Ltd — Income Statement: Revenue & Gross Profit
Series (AUD Mn)FY2022FY2023FY2024FY2025FY2026
Revenue55.689.8109.2103.485.5
Revenue less materials & consumables (A$m), analyst calc.—24.334.134.527.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.